Benzoyl-piperidine derivatives as dual modulators of the 5-HT2a and D3 receptors

Details for Australian Patent Application No. 2008285729 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Steward, Lucinda; Jaeschke, Georg; Rodriguez Sarmiento, Rosa Maria; Gobbi, Luca

Agent Spruson & Ferguson

Pub. Number AU-B-2008285729 ( Modified Examination )

PCT Pub. Number WO2009/019174

Priority 07114119.6 09.08.07 EP

Filing date 30 July 2008

Wipo publication date 12 February 2009

Acceptance publication date 1 November 2012

International Classifications

C07D 211/32 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/019174 Priority application(s): WO2009/019174

1 November 2012 Application Accepted

  Published as AU-B-2008285729 ( Modified Examination )

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008285746-Modular radar architecture

2008285722-6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis